Related Experiment Videos
Prediction by mathematical simulation of different pathophysiological effects on D-sorbitol bioavailability
1Azienda Ospedaliera San Giovanni Battista di Torino, Divisione di Medicina Generale A e Laboratorio di Informatica Clinica, Italy. medgen1.molinette@mail.cs.interbusiness .it
Computers in Biology and Medicine
|July 31, 1998
Summary
This study models how changes in hepatic extraction, portal inflow, and renal elimination affect D-sorbitol bioavailability in cirrhosis patients. Mathematical simulations explain variations in bioavailability data, aiding understanding of cirrhotic patient physiology.
Area of Science:
- Pharmacokinetics and Mathematical Modeling
- Hepatology and Clinical Physiology
- Biopharmaceutical Sciences
Background:
- D-sorbitol bioavailability in cirrhotic patients exhibits significant variability.
- Understanding factors influencing D-sorbitol bioavailability is crucial for managing liver disease.
Purpose of the Study:
- To mathematically model the impact of hepatic extraction ratio (E), fractional portal inflow (P), and renal elimination ratio (R) on D-sorbitol bioavailability.
- To explain the observed dispersion in regression lines of D-sorbitol urinary outputs (Uma, Uha vs. Usv).
Main Methods:
- Application of a mathematical model simulating hepatic circulation.
- Independent variation of E, P, and R parameters.
- Simulation of specific pathophysiological conditions (hepatic arterialization, hepatofugal flow).
Main Results:
- Computational results explain the wide dispersion of experimental data in D-sorbitol bioavailability studies.
- The model provides plausible explanations for unexpected findings in previous research.
- Simulations highlight the sensitivity of D-sorbitol bioavailability to changes in hepatic and renal parameters.
Conclusions:
- Mathematical modeling effectively explains variability in D-sorbitol bioavailability in cirrhosis.
- The study offers insights into the complex interplay of hepatic and renal functions in D-sorbitol disposition.
- Findings contribute to a better understanding of drug bioavailability in liver disease.